Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-21-019770
Filing Date
2021-06-03
Accepted
2021-06-03 17:21:40
Documents
5
Effectiveness Date
2021-06-03

Document Format Files

Seq Description Document Type Size
1 S-8 brhc10025341_s8.htm S-8 70836
2 EXHIBIT 5.1 brhc10025341_ex5-1.htm EX-5.1 11496
3 EXHIBIT 23.1 brhc10025341_ex23-1.htm EX-23.1 2163
4 EXHIBIT 23.2 brhc10025341_ex23-2.htm EX-23.2 2271
5 image00002.jpg GRAPHIC 2298
  Complete submission text file 0001140361-21-019770.txt   91380
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-256760 | Film No.: 21993612
SIC: 2834 Pharmaceutical Preparations